Page last updated: 2024-08-16

pyrimethamine and af-219

pyrimethamine has been researched along with af-219 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Evers, R; Garrett, G; Hussain, A; Iwamoto, M; Li, Y; Ma, B; Min, KC; Nussbaum, JC; Stoch, SA1

Other Studies

1 other study(ies) available for pyrimethamine and af-219

ArticleYear
Assessment of the Effect of Pyrimethamine, a Potent Inhibitor of Multidrug and Toxin Extrusion Protein 1/2K, on the Pharmacokinetics of Gefapixant (MK-7264), a P2X3 Receptor Antagonist.
    Clinical pharmacology in drug development, 2022, Volume: 11, Issue:1

    Topics: Humans; Purinergic P2X Receptor Antagonists; Pyrimethamine; Pyrimidines; Receptors, Purinergic P2X3; Sulfonamides

2022